Australia microfluidics market is anticipated
to undergo significant growth during the forecast period, 2024-2028. The rising
penetration of microfluidics devices in numerous fields of research and
diagnosis along with rising incidence of chronic diseases are expected to
facilitate the growth of the market. For instances, in 2022, the University
of Technology Sydney (UTS), Australia has developed a 3D printed system for
harvesting stem cells from bioreactors. The technology uses 3D printing and
microfluidics to integrate several production steps into one device that can
help make stem cell therapies more widely available to patients at a lower cost.
The well-established healthcare system and better reimbursement policies in
the country are bolstering the growth of the market. Besides, the other factors
which are supporting the growth are the evolution of advanced lab-on-a-chip
technologies, growing demand for point-of-care testing and adoption of high-throughput screening
methodologies.
Microfluids are widely used in DNA
analysis, cell patterning and separation & manipulation of cells. They are
also used in research for the study of antibiotic drug-resistant bacteria. Furthermore,
wide application of microfluidics in tissue engineering, pathogen detection in
human/animals and point-of-care analysis are expected to act as major growth
drivers for Australia microfluidics market.
Australia microfluidics market is
segmented into product type, material, application, end user and
region. Based on application, the market
is categorized into in vitro diagnostics, pharmaceutical & life
science research & manufacturing, and therapeutics. Among them, the in vitro
diagnostics segment is expected to dominate the market during the forecast
period. This is attributed to the high demand for point-of-care testing in
Australia. Also, the rising occurrences of target diseases, along with
increasing demand for PoC testing are anticipated to augment the growth of the
market in upcoming years.
Major companies operating in Australia
microfluidics market include MTPConnect, SCHOTT AG, Microfluidics Biomedical
Pty. Ltd., SDR Scientific Pty Ltd, WHITE RABBIT SCIENTIFIC LIMITED, Australian
National Fabrication Facility, AI Fluidics PTY LTD, Merck Pty. Ltd., and Thermo
Fisher Scientific Inc. Leading companies are adopting growth strategies like
new product launches and mergers & acquisitions to enhance their market
presence.
Objective
of the Study:
- To analyze and forecast the market size of Australia microfluidics market.
- To forecast Australia microfluidics market based on component type, material,
application, sector, end user, company and
regional distribution.
- To identify drivers and challenges for Australia microfluidics market.
- To examine competitive developments such as expansions, new product
launches, mergers & acquisitions etc. in Australia microfluidics market.
- To identify and analyze the profile of leading players operating in
the Australia microfluidics market.
Download Free Sample Report
TechSci Research performed both primary as well as
exhaustive secondary research for this study. Initially, TechSci Research
sourced a list of microfluidic manufacturing companies across Australia.
Subsequently, TechSci Research conducted primary research surveys with the
identified companies. While interviewing, the respondents were also enquired
about their competitors. Through this technique, TechSci Research could include
the companies which could not be identified due to the limitations of secondary
research.
TechSci
Research calculated Australia microfluidics market size using a bottom-up
approach, where data for various end user industries and its application across
various product types were recorded and forecast for the future years. TechSci
Research sourced these values from the industry experts and company
representatives and externally validated through analyzing historical data of
these product types and applications for getting an appropriate, overall market
size. Various secondary sources such as company websites, news articles, press
releases, company annual reports, investor presentations and financial reports
were also used by TechSci Research.
Key Target Audience:
- Microfluidic manufacturers, companies, partners,
and other stakeholders
- Government bodies such as regulating
authorities and policy makers
- Organizations, industry associations, forums
and alliances related to microfluidics
- Market research and consulting firms
The study is useful in providing answers to several critical
questions that are important for the industry stakeholders such as microfluidic
manufacturing companies, end users etc., besides allowing them in strategizing
investments and capitalizing on market opportunities.
Attribute | Details |
Base Year | 2022 |
Historical Data | 2018 – 2021 |
Estimated Year | 2023 |
Forecast Period | 2024 – 2028 |
Quantitative Units | Revenue in USD Million and CAGR for
2018-2022 and 2023E-2028F |
Report coverage | Revenue forecast, Company share, Competitive
landscape, Growth factors, and Trends |
Segments covered | ·
Product Type ·
Material ·
Application ·
End User ·
Region |
Regional scope | New South Wales, Victoria, Queensland,
Tasmania, Northern Territory, Western Australia, South Australia |
Key companies profiled | MTPConnect, SCHOTT AG, Microfluidics
Biomedical Pty. Ltd., SDR Scientific Pty Ltd, WHITE RABBIT SCIENTIFIC
LIMITED, Australian National Fabrication Facility, AI Fluidics PTY LTD, Merck
Pty. Ltd., and Thermo Fisher Scientific Inc.. |
Customization scope | 10% free report customization with
purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to
meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can
also provide the editable version of the report in PPT/Word format on special
request) |
Report Scope:
In this report, Australia microfluidics market has been
segmented into following categories, in addition to the industry trends which
have also been detailed below:
- Australia Microfluidics Market,
By Product Type:
- Microfluidic
Based Devices
- Microfluidic
Components
·
Australia
Microfluidics Market,
By Material:
- Glass
- Silicon
- Polymers
- Others
- Australia Microfluidics Market, By Application:
- In Vitro diagnostics
- Pharmaceutical & Life Science
Research & Manufacturing
- Therapeutics
- Australia Microfluidics Market, By End User:
- Hospitals & Diagnostic Centers
- Academic & Research Institutes
- Pharmaceutical & Biotechnology
Companies
- Australia Microfluidics Market, By Region:
- New South Wales
- Victoria
- Queensland
- Western Australia
- South Australia
- Tasmania
- Northern Territory
Competitive
Landscape
Company Profiles: Detailed analysis of the major
companies present in Australia microfluidics market.
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following
customization options are available for the report:
Company
Information
- Detailed analysis and profiling of
additional market players (up to five).
Profit
Margin Analysis
- Profit margin analysis in case of
direct and indirect sales channel.
It is an upcoming report to be released soon. If
you wish an early delivery of this report or want to confirm the date of
release, please contact us at [email protected]